PharmAla Biotech Australia Ties Up with UK CDMO to Manufacture ALA-002
PharmAla Biotech Australia has contracted a UK-based CDMO to manufacture the drug substance for ALA-002, its patented non-racemic MDMA formulation, ahead of planned phase 2a/2b clinical trials for social anxiety disorder expected to begin in 2026.
Clinical Trials | 16/12/2025 | By News Bureau
AstraZeneca Plans USD 2 Billion Manufacturing Investment in Maryland
AstraZeneca will invest USD 2 billion to expand its biologics manufacturing in Maryland, boosting production of cancer, rare disease, and chronic therapies while supporting around 2,600 jobs.
Clinical Trials | 24/11/2025 | By Dineshwori
UK Halves Clinical Trial Approval Times Through Major Digital Reforms
Backed by major reforms and new digital platforms at the Medicines and Healthcare products Regulatory Agency (MHRA), the UK has reduced the average clinical trial approval time by more than half — from 91 days to just 41 days.
Clinical Trials | 08/10/2025 | By Dineshwori | 207
WHO launches Global Clinical Trials Forum
The Forum responds to World Health Assembly resolution WHA75.8, which called on WHO to improve the quality and coordination of clinical trials to generate high-quality evidence for health decision-making.
Clinical Trials | 08/10/2025 | By Dineshwori | 135
Amgen Partners with Veeva Systems to Drive Innovation in Clinical Trials
Veeva Systems, a leading provider of cloud-based software, data, and consulting services for the life sciences industry, has announced a strategic collaboration with biotechnology giant Amgen to advance clinical trial innovation.
Clinical Trials | 01/09/2025 | By Darshana | 176
CDSCO Mandates Online Submission of CGTP Clinical Trial Applications via SUGAM Portal
For now on, offline submissions of clinical trial applications for Cell and Gene Therapy Products (CGTPs) will not be accepted by the CDSCO.
Clinical Trials | 11/07/2025 | By Dineshwori | 235
DHL Group Acquires CRYOPDP from Cryoport to Boost DHL Health Logistics
Going forward, DHL Supply Chain will further build the potential of its Pharma Specialized Network solution by leveraging the specialty courier expertise of newly acquired CRYOPDP and the global air capabilities of DHL Express and DHL Global Forwarding.
Clinical Trials | 05/04/2025 | By Aishwarya | 228
Chance Pharma Receives New Funding to Develop Innovative Inhalation Therapies
Chance Pharma operates state-of-the-art production facilities compliant with FDA and EMA quality standards, underscoring its strong capabilities in both R&D and manufacturing.
Clinical Trials | 18/03/2025 | By Aishwarya | 169
Advarra Launches Comprehensive Solution to Improve Collaboration on Clinical Trials
The new offering combines the Longboat technology acquired by Advarra in 2020, which now has over 225,000 users, with Advarra's study startup delivery program and industry-adopted single sign-on capabilities.
Clinical Trials | 22/01/2025 | By Aishwarya | 675
Biofidelity and CellCarta Announce Partnership to Enhance NSCLC Clinical Trials with Aspyre Lung
Aspyre Lung simplifies the detection of established non-small cell lung cancer (NSCLC) biomarkers by analysing both DNA and RNA from tissue and blood using a streamlined four-step workflow.
Clinical Trials | 17/01/2025 | By Abha | 223
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy